What’s the deal with healthcare in the U.S. right now?

October 30, 2017

It seems like one day America is making headway on a new healthcare initiative or bill, and then the next day any progress towards an agreement comes to a halt. 


Repealing and replacing the Affordable Care Act (aka Obamacare) has been more challenging than the GOP anticipated.

Ever since Trump took office in January, Republicans and Democrats have debated how to move forward with a healthcare plan for the country. Earlier this month, two senators reached an agreement on a bipartisan healthcare bill, which intended to stabilize insurance markets by restoring cost-sharing reduction payments. It looked like we were on our way to a long anticipated answer to our question — “What’s going on with healthcare?” — but then Trump pulled out of the decision to move forward, accusing the bill of “bailing out” insurance companies..

As 2017 winds down, the constant flux and ambiguity has a lot of people wondering — what’s the deal with healthcare in the U.S. and how will the uncertainty affect people in 2018?

While we don’t have all the answers, this is what we can break down for you.

Healthcare right now

Healthcare, looking towards the future

We’ll keep you posted as things play out, but in the meantime, make sure you have a game plan for you and your family’s healthcare next year.

How do you feel about the current state of healthcare in America? Tell us in the comments or share with us on Facebook.


View Comments on This Article (1)   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Obamacare sign-ups surge. This and other news.
5 Things To Know About ACA At Year 5
Lawmakers aim for small, bipartisan healthcare changes. This and other news.

Featured Articles

Governor Cooper Issues Stay-at-Home order
Announcing @CoronavirusNC on Twitter
When Your Doctor Is Also A Lobbyist: Inside The War Over Surprise Medical Bills
Cost of COVID-19: Steps you can take right now to save on health care costs
Benchmarking, Not Arbitration, is the Answer to America’s Surprise Billing Problem
New Year, Same Price Hikes From Big Pharma